FDA inspection
Molecular Imaging Program at Stanford: FDA inspection ending Oct 4, 2024
FDA inspection 1251796 · Voluntary Action Indicated (VAI) · Palo Alto, CA
Key facts
| Inspection ID | 1251796 |
|---|---|
| Firm | Molecular Imaging Program at Stanford |
| FEI number | 3005712028 |
| Address | 1201 Welch Rd |
| City | Palo Alto |
| State | CA |
| ZIP | 94305 |
| Country | United States |
| Fiscal year | 2025 |
| Inspection end date | Oct 4, 2024 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data